← Open Payments lookup

LINDSAY MIRAKIAN: Open Payments

NPI 1497351704 · MOUNT LAUREL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,309 in 58 payments from 10 companies in 2025. Trend: 2023 $1,072 · 2024 $1,236 · 2025 $1,309

Food & beverage: $1,309
CompanyPaymentsAmount
ABBVIE INC.9$233
Takeda Pharmaceuticals U.S.A., Inc.8$220
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$192
GENZYME CORPORATION6$166
Janssen Biotech, Inc.8$158
Regeneron Healthcare Solutions, Inc.6$112
Ardelyx, Inc.5$97
Aimmune Therapeutics, Inc.2$73
Celltrion USA Inc.1$29
Madrigal Pharmaceuticals1$28

Products named: DUPIXENT, ENTYVIO, XIFAXAN, TREMFYA, IBSRELA, ZENPEP, RINVOQ, SKYRIZI.

Industry payments across NJ — which companies pay providers there.